By Dominic Chopping Novo Nordisk is buying Cardior Pharmaceuticals for up to $1.03 billion euros as the Wegovy maker moves to strengthen its pipeline of drugs to treat cardiovascular disease.
Health-care companies ticked down amid skepticism about the deal market. Novo Nordisk agreed to buy smaller rival Cardior Pharmaceuticals for up to $1.11 billion as the Wegovy maker seeks to. -March 25, 2024 at 05:13 pm EDT
- MarketScreener
Denmark s Novo Nordisk strikes deal to buy Cardior Pharmaceuticals yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Stocks Fall to Kick Off This Quarter s Final Week: Markets Wrap swissinfo.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swissinfo.ch Daily Mail and Mail on Sunday newspapers.